Endoglin and TGF-β signaling in glioblastoma
Open Access
- 20 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell and tissue research
- Vol. 384 (3), 613-624
- https://doi.org/10.1007/s00441-020-03323-5
Abstract
Microvascular proliferation is a key feature of glioblastoma and neovascularization has been implicated in tumor progression. Glioblastomas use pro-angiogenic factors such as vascular endothelial growth factor (VEGF) for new blood vessel formation. Yet, anti-VEGF therapy does not prolong overall survival so that alternative angiogenic pathways may need to be explored as drug targets. Both glioma cells and glioma-associated endothelial cells produce TGF-β superfamily ligands which bind TGF-β receptors (TGF-βR). The TGF-βR type III endoglin (CD105), is a marker of proliferating endothelium that has already been studied as a potential therapeutic target. We studied endoglin expression in glioblastoma tissue and in glioma-associated endothelial cells in a cohort of 52 newly diagnosed and 10 recurrent glioblastoma patients by immunohistochemistry and by ex vivo single-cell gene expression profiling of 6 tumors. Endoglin protein levels were similar in tumor stroma and endothelium and correlated within tumors. Similarly, endoglin mRNA determined by ex vivo single-cell gene expression profiling was expressed in both compartments. There was positive correlation between endoglin and proteins of TGF-β superfamily signaling. No prognostic role of endoglin expression in either compartment was identified. Endoglin gene silencing in T98G glioma cells and in human cerebral microvascular endothelial cells (hCMEC) did not affect constitutive or exogenous TGF-β superfamily ligand-dependent signaling, except for a minor facilitation of pSmad1/5 signaling in hCMEC. These observations challenge the notion that endoglin might become a promising therapeutic target in glioblastoma.Keywords
Funding Information
- University of Zurich
This publication has 44 references indexed in Scilit:
- CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade gliomaActa Neuropathologica, 2012
- Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor GrowthOnline Journal of Public Health Informatics, 2011
- Transdifferentiation of glioblastoma cells into vascular endothelial cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb studyNeuro-Oncology, 2010
- Matrix Metalloproteinase-14 (MT1-MMP)–Mediated Endoglin Shedding Inhibits Tumor AngiogenesisCancer Research, 2010
- The emerging role of TGF-β superfamily coreceptors in cancerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Modulation of TGF‐β activity by latent TGF‐β‐binding protein 1 in human malignant glioma cellsInternational Journal of Cancer, 2009
- Blood‐brain barrier‐specific properties of a human adult brain endothelial cell lineThe FASEB Journal, 2005
- Non-Smad TGF-β signalsJournal of Cell Science, 2005
- Interaction and functional interplay between endoglin and ALK‐1, two components of the endothelial transforming growth factor‐β receptor complexJournal of Cellular Physiology, 2005